G M Pieper
Overview
Explore the profile of G M Pieper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
928
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pieper G, Olds C, Hilton G, Lindholm P, Adams M, Roza A
Antioxid Redox Signal
. 2001 Apr;
3(1):81-8.
PMID: 11291601
Nitric oxide production via inducible nitric oxide synthase (iNOS) is believed to play a role in cardiac allograft rejection. Previously, we showed that antioxidants can significantly prolong cardiac graft survival,...
2.
Pieper G, Roza A, Adams M, Johnson M, Hilton G, Felix C, et al.
J Heart Lung Transplant
. 2001 Mar;
20(2):157.
PMID: 11250230
No abstract available.
3.
Pieper G, Siebeneich W
Eur J Pharmacol
. 2000 Sep;
403(1-2):129-32.
PMID: 10969153
The effect of chronic treatment with the angiotensin converting enzyme inhibitor, temocapril, on prevention of endothelial dysfunction was evaluated in an experimental model of diabetes mellitus. Endothelium-dependent relaxation to acetylcholine...
4.
Pieper G, Mizoguchi H, Ohsawa M, Kamei J, Nagase H, TSENG L
Eur J Pharmacol
. 2000 Aug;
401(3):375-9.
PMID: 10936496
Previous evaluation of antinociceptive action in experimental diabetes has been conducted almost exclusively in chemically induced diabetes mellitus. The purpose of the present study was to evaluate antinociceptive response and...
5.
Pieper G, Cooper M, Johnson C, Adams M, Felix C, Roza A
J Cardiovasc Pharmacol
. 2000 Jan;
35(1):114-20.
PMID: 10630741
Nitric oxide synthase (NOS) inhibitors have been shown to reduce NO but yield conflicting results on cardiac allograft survival. In this study, we provide an alternative approach specifically to examine...
6.
Pieper G, Lai C
Jpn J Pharmacol
. 1999 Sep;
80(4):359-70.
PMID: 10496337
We utilized the nitric oxide (NO) scavenger N-methyl-D-glucamine dithiocarbamate-Fe2+ (MGD-Fe) to characterize the role of NO in basal and acetylcholine (ACh)-stimulated relaxation arising from the endothelium of control vs diabetic...
7.
Pieper G
Diabetologia
. 1999 Mar;
42(2):204-13.
PMID: 10064101
Long-term diabetes mellitus is characterized by impaired endothelium-dependent relaxation. In contrast, there is limited information on endothelial function in the early stages of the disease. In this study, we evaluated...
8.
Auchampach J, Pieper G, Cavero I, Gross G
Basic Res Cardiol
. 1998 Dec;
93(5):361-71.
PMID: 9833148
The effect of the platelet activating factor antagonist RP 59227 (Tulopafant) on myocardial infarct size was compared to that of a vehicle-treated control group in barbital-anesthetized dogs subjected to 90...
9.
Pieper G, Dembny K, Siebeneich W
Diabetologia
. 1998 Oct;
41(10):1220-6.
PMID: 9794111
Substantial evidence exists that diabetes results in impaired endothelial dysfunction suggesting diminished nitric oxide production from diabetic endothelium. It is not known what factors contribute to the development of this...
10.
Dembny K, Roza A, JOHNSON C, Adams M, Pieper G
Clin Chim Acta
. 1998 Aug;
275(1):107-14.
PMID: 9706849
No abstract available.